59 related articles for article (PubMed ID: 7702971)
1. High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma.
Al-Ward R; Brondani VB; Sawani S; Potter CL; Xu G; Waguespack SG; Varghese J; Habra MA; Lu Y; Jimenez C
Clin Nucl Med; 2024 Jul; 49(7):610-620. PubMed ID: 38630996
[TBL] [Abstract][Full Text] [Related]
2. EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for
Gear J; Chiesa C; Lassmann M; Gabiña PM; Tran-Gia J; Stokke C; Flux G;
EJNMMI Phys; 2020 Mar; 7(1):15. PubMed ID: 32144574
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic radionuclides in nuclear medicine: current and future prospects.
Yeong CH; Cheng MH; Ng KH
J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic possibilities in metastatic pheochromocytoma].
Vierhapper H; Raber W
Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
[TBL] [Abstract][Full Text] [Related]
5. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
Nakabeppu Y; Nakajo M
Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
[TBL] [Abstract][Full Text] [Related]
6. [Nuclear medical therapy of pheochromocytoma].
Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
[TBL] [Abstract][Full Text] [Related]
7. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
[TBL] [Abstract][Full Text] [Related]
8. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
[TBL] [Abstract][Full Text] [Related]
10. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
Beierwaltes WH
Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
[TBL] [Abstract][Full Text] [Related]
11. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.
Wieland DM; Wu J; Brown LE; Mangner TJ; Swanson DP; Beierwaltes WH
J Nucl Med; 1980 Apr; 21(4):349-53. PubMed ID: 7381563
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic localization of pheochromocytoma.
Sisson JC; Frager MS; Valk TW; Gross MD; Swanson DP; Wieland DM; Tobes MC; Beierwaltes WH; Thompson NW
N Engl J Med; 1981 Jul; 305(1):12-7. PubMed ID: 7231514
[TBL] [Abstract][Full Text] [Related]
13. Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication.
Wieland DM; Brown LE; Tobes MC; Rogers WL; Marsh DD; Mangner TJ; Swanson DP; Beierwaltes WH
J Nucl Med; 1981 Apr; 22(4):358-64. PubMed ID: 7205383
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.
Kimmig B; Brandeis WE; Eisenhut M; Bubeck B; Hermann HJ; zum Winkel K
J Nucl Med; 1984 Jul; 25(7):773-5. PubMed ID: 6737076
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
